Ultragenyx Pharmaceutical Inc. Payments to Acquire Property, Plant, and Equipment in USD from 2012 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Ultragenyx Pharmaceutical Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2012 to Q1 2025.
  • Ultragenyx Pharmaceutical Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $1.32M, a 58.8% decline year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $7.49M, a 83.1% decline from 2023.
  • Ultragenyx Pharmaceutical Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $44.3M, a 61.9% decline from 2022.
  • Ultragenyx Pharmaceutical Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $116M, a 58.9% increase from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)

Ultragenyx Pharmaceutical Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $1.32M -$1.89M -58.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q1 2024 $3.21M -$21.8M -87.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q1 2023 $25M -$7.15M -22.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q1 2022 $32.2M +$15.8M +96.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q1 2021 $16.4M +$2.32M +16.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 $14.1M +$11M +361% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $3.06M +$2.58M +544% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $475K -$10K -2.06% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 $485K -$992K -67.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 $1.48M +$1.02M +222% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q1 2015 $459K -$110K -19.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $569K +$392K +221% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q1 2013 $177K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12

Ultragenyx Pharmaceutical Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $7.49M -$36.8M -83.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-19
2023 $44.3M -$71.9M -61.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-19
2022 $116M +$43M +58.9% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-19
2021 $73.1M +$29.2M +66.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 $43.9M +$19.1M +76.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $24.8M +$20.8M +509% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $4.08M +$1.28M +45.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-12
2017 $2.79M -$7.4M -72.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-14
2016 $10.2M +$5.23M +106% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-20
2015 $4.96M +$2.81M +131% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-21
2014 $2.15M +$1.74M +428% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $407K -$684K -62.7% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 $1.09M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.